These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 21825225

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Significance of prolyl hydroxylase 2 in the interference of aryl hydrocarbon receptor and hypoxia-inducible factor-1 alpha signaling.
    Seifert A, Katschinski DM, Tonack S, Fischer B, Navarrete Santos A.
    Chem Res Toxicol; 2008 Feb; 21(2):341-8. PubMed ID: 18072750
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells.
    Wang Z, Tang L, Zhu Q, Yi F, Zhang F, Li PL, Li N.
    Kidney Int; 2011 Feb; 79(3):300-10. PubMed ID: 20881940
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A new role for PHD in chemotherapy.
    Xu RH, Huang P.
    Cancer Cell; 2012 Aug 14; 22(2):143-4. PubMed ID: 22897845
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of a viral prolyl hydroxylase.
    Langley GW, Abboud MI, Lohans CT, Schofield CJ.
    Bioorg Med Chem; 2019 Jun 15; 27(12):2405-2412. PubMed ID: 30737136
    [Abstract] [Full Text] [Related]

  • 14. Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy.
    Moslehi J, Minamishima YA, Shi J, Neuberg D, Charytan DM, Padera RF, Signoretti S, Liao R, Kaelin WG.
    Circulation; 2010 Sep 07; 122(10):1004-16. PubMed ID: 20733101
    [Abstract] [Full Text] [Related]

  • 15. Prolyl hydroxylases and therapeutics.
    Smith TG, Talbot NP.
    Antioxid Redox Signal; 2010 Apr 07; 12(4):431-3. PubMed ID: 19761407
    [Abstract] [Full Text] [Related]

  • 16. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ, Tian YM, Mole DR, Harris AL.
    Circ Res; 2004 Jul 23; 95(2):162-9. PubMed ID: 15192023
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1).
    Chowdhury R, Flashman E, Mecinović J, Kramer HB, Kessler BM, Frapart YM, Boucher JL, Clifton IJ, McDonough MA, Schofield CJ.
    J Mol Biol; 2011 Jul 08; 410(2):268-79. PubMed ID: 21601578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.